nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0239	0.0239	CcSEcCtD
Pentazocine—Visual impairment—Vandetanib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Pentazocine—Erythema multiforme—Vandetanib—thyroid cancer	0.0203	0.0203	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0188	0.0188	CcSEcCtD
Pentazocine—Dysgeusia—Vandetanib—thyroid cancer	0.0183	0.0183	CcSEcCtD
Pentazocine—Muscle spasms—Vandetanib—thyroid cancer	0.018	0.018	CcSEcCtD
Pentazocine—Vision blurred—Vandetanib—thyroid cancer	0.0176	0.0176	CcSEcCtD
Pentazocine—Tremor—Vandetanib—thyroid cancer	0.0175	0.0175	CcSEcCtD
Pentazocine—Abdominal discomfort—Sorafenib—thyroid cancer	0.0173	0.0173	CcSEcCtD
Pentazocine—Loss of consciousness—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Pentazocine—Hypertension—Vandetanib—thyroid cancer	0.0161	0.0161	CcSEcCtD
Pentazocine—Dry mouth—Vandetanib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Pentazocine—Nystagmus—Epirubicin—thyroid cancer	0.0149	0.0149	CcSEcCtD
Pentazocine—Nystagmus—Doxorubicin—thyroid cancer	0.0138	0.0138	CcSEcCtD
Pentazocine—Insomnia—Vandetanib—thyroid cancer	0.0138	0.0138	CcSEcCtD
Pentazocine—Paraesthesia—Vandetanib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Pentazocine—Erythema multiforme—Sorafenib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Pentazocine—Dyspnoea—Vandetanib—thyroid cancer	0.0136	0.0136	CcSEcCtD
Pentazocine—Tinnitus—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Pentazocine—Flushing—Sorafenib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Pentazocine—Decreased appetite—Vandetanib—thyroid cancer	0.0133	0.0133	CcSEcCtD
Pentazocine—Constipation—Vandetanib—thyroid cancer	0.013	0.013	CcSEcCtD
Pentazocine—Dysgeusia—Sorafenib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Pentazocine—Muscle spasms—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Pentazocine—Syncope—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Pentazocine—Ulcer—Epirubicin—thyroid cancer	0.0113	0.0113	CcSEcCtD
Pentazocine—Loss of consciousness—Sorafenib—thyroid cancer	0.0111	0.0111	CcSEcCtD
Pentazocine—Asthenia—Vandetanib—thyroid cancer	0.0109	0.0109	CcSEcCtD
Pentazocine—Hypertension—Sorafenib—thyroid cancer	0.0109	0.0109	CcSEcCtD
Pentazocine—Pruritus—Vandetanib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Pentazocine—Dry mouth—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Pentazocine—Diarrhoea—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Pentazocine—Ulcer—Doxorubicin—thyroid cancer	0.0104	0.0104	CcSEcCtD
Pentazocine—Anaphylactic shock—Sorafenib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Pentazocine—Shock—Sorafenib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Pentazocine—Dizziness—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Pentazocine—Anorexia—Sorafenib—thyroid cancer	0.0098	0.0098	CcSEcCtD
Pentazocine—Vomiting—Vandetanib—thyroid cancer	0.00969	0.00969	CcSEcCtD
Pentazocine—Dermatitis—Vandetanib—thyroid cancer	0.0096	0.0096	CcSEcCtD
Pentazocine—Headache—Vandetanib—thyroid cancer	0.00955	0.00955	CcSEcCtD
Pentazocine—Dyspnoea—Sorafenib—thyroid cancer	0.00917	0.00917	CcSEcCtD
Pentazocine—Nausea—Vandetanib—thyroid cancer	0.00905	0.00905	CcSEcCtD
Pentazocine—Decreased appetite—Sorafenib—thyroid cancer	0.00894	0.00894	CcSEcCtD
Pentazocine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00885	0.00885	CcSEcCtD
Pentazocine—Constipation—Sorafenib—thyroid cancer	0.00879	0.00879	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00819	0.00819	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—thyroid cancer	0.00773	0.00773	CcSEcCtD
Pentazocine—Hypersensitivity—Sorafenib—thyroid cancer	0.00758	0.00758	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—thyroid cancer	0.00746	0.00746	CcSEcCtD
Pentazocine—Asthenia—Sorafenib—thyroid cancer	0.00738	0.00738	CcSEcCtD
Pentazocine—Pruritus—Sorafenib—thyroid cancer	0.00728	0.00728	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—thyroid cancer	0.00715	0.00715	CcSEcCtD
Pentazocine—Diarrhoea—Sorafenib—thyroid cancer	0.00704	0.00704	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00696	0.00696	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—thyroid cancer	0.00691	0.00691	CcSEcCtD
Pentazocine—Dizziness—Sorafenib—thyroid cancer	0.0068	0.0068	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—thyroid cancer	0.00662	0.00662	CcSEcCtD
Pentazocine—Vomiting—Sorafenib—thyroid cancer	0.00654	0.00654	CcSEcCtD
Pentazocine—Dermatitis—Sorafenib—thyroid cancer	0.00648	0.00648	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00644	0.00644	CcSEcCtD
Pentazocine—Headache—Sorafenib—thyroid cancer	0.00644	0.00644	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—thyroid cancer	0.00612	0.00612	CcSEcCtD
Pentazocine—Nausea—Sorafenib—thyroid cancer	0.00611	0.00611	CcSEcCtD
Pentazocine—Sweating—Epirubicin—thyroid cancer	0.00571	0.00571	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—thyroid cancer	0.00556	0.00556	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—thyroid cancer	0.00529	0.00529	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—thyroid cancer	0.00515	0.00515	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—thyroid cancer	0.00506	0.00506	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Pentazocine—Flushing—Epirubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Pentazocine—Chills—Epirubicin—thyroid cancer	0.0048	0.0048	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—thyroid cancer	0.00468	0.00468	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—thyroid cancer	0.00456	0.00456	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—thyroid cancer	0.00448	0.00448	CcSEcCtD
Pentazocine—Chills—Doxorubicin—thyroid cancer	0.00444	0.00444	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Pentazocine—Agitation—Epirubicin—thyroid cancer	0.00428	0.00428	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—thyroid cancer	0.00418	0.00418	CcSEcCtD
Pentazocine—Syncope—Epirubicin—thyroid cancer	0.00418	0.00418	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—thyroid cancer	0.00402	0.00402	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—thyroid cancer	0.00388	0.00388	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—thyroid cancer	0.00383	0.00383	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—thyroid cancer	0.0038	0.0038	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00379	0.00379	CcSEcCtD
Pentazocine—Shock—Epirubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—thyroid cancer	0.00372	0.00372	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—thyroid cancer	0.00362	0.00362	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—thyroid cancer	0.00359	0.00359	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Pentazocine—Shock—Doxorubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—thyroid cancer	0.00344	0.00344	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—thyroid cancer	0.00338	0.00338	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Pentazocine—Constipation—Epirubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—thyroid cancer	0.00318	0.00318	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—thyroid cancer	0.00316	0.00316	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Pentazocine—Headache—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Pentazocine—Nausea—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Pentazocine—Headache—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
